How Green Minds Has Supported Clients Across Multiple Ozempic and GLP-1 Studies?
The Context
Over the past one to two years, Green Minds has supported multiple projects across the Ozempic and wider GLP-1 landscape, connecting clients with the specialist and patient perspectives needed to understand a rapidly changing market.
The Client Challenge
Clients needed timely, evidence-led insight into prescribing behaviour, patient experience, access, reimbursement, competitive dynamics, and future opportunities across diabetes and obesity care.
Selected Project Experience
US Clinician Study:
Recruited primary-care physicians, endocrinologists, and hepatologists to explore the potential of GLP-1 therapies across type 2 diabetes, obesity, and related comorbidities.
Multi-Market Commercial Study:
Connected clients with industry experts to assess semaglutide market dynamics, pricing, reimbursement, off-label use, and potential future generic or biosimilar entry.
Germany Patient Study:
Recruited self-pay obesity patients for qualitative research focused on treatment access, patient experience, and market opportunity.
The Value Delivered
Our support gave clients direct access to relevant stakeholder voices and helped them develop a clearer understanding of market dynamics, stakeholder priorities, access barriers, and emerging opportunities across the GLP-1 landscape.
How Green Minds Adds Value
Precisely Matched Participants
Healthcare professionals, industry experts, decision-makers, and patients aligned with each project brief.
Access to Hard-to-Reach Audiences
Relevant perspectives from niche stakeholder groups across markets.
Tailored Screening
Carefully designed recruitment criteria to improve participant relevance and research quality.
Responsive Project Coordination
Efficient recruitment and communication to help keep projects on track.
Stronger Decision Support
Relevant stakeholder insight to help clients evaluate GLP-1 market needs, opportunities, and strategic priorities.
